Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» PLAN B Revisited: FDA Rules on One-Step Exclusivity and ANDA Labeling Carve-Outs
PLAN B Revisited: FDA Rules on One-Step Exclusivity and ANDA Labeling Carve-Outs
PLAN B Revisited: FDA Rules on One-Step Exclusivity and ANDA Labeling Carve-Outs
Submitted by
admin
on February 26, 2014 - 9:15am
Source:
FDA Law Blog
News Tags:
FDA
exclusivity
ANDAs
Plan B contraceptive
Teva Pharmaceuticals
Headline:
PLAN B Revisited: FDA Rules on One-Step Exclusivity and ANDA Labeling Carve-Outs
Do Not Allow Advertisers to Use My Personal information
